Remove Data Privacy Remove Events Remove Healthcare Remove Manufacturing
article thumbnail

Delivering responsible AI in the healthcare and life sciences industry

IBM Big Data Hub

With today’s new generative AI products, trust, security and regulatory issues remain top concerns for government healthcare officials and C-suite leaders representing biopharmaceutical companies, health systems, medical device manufacturers and other organizations. And institutional innovation can play a role to help.

article thumbnail

The Week in Cyber Security and Data Privacy: 15 – 21 January 2024

IT Governance

Source (New) Manufacturing Saudi Arabia Yes 86.16 GB JSP Pharmaceutical Manufacturing (Thailand) PCL Source (New) Manufacturing Thailand Yes >80 GB TREZOR Source (New) Crypto France Yes Nearly 66,000 Oak View Group Source (New) Leisure USA Yes 58,935 Innefu Labs Pvt.

article thumbnail

Anonymization & Pseudonymization as Tools for Cross-Border Discovery Compliance

ARMA International

However, the data privacy and data protection rules of many countries prohibit companies from transferring to the United States (or making accessible in the United States) documents containing personal information of persons within their countries (“data subjects”). discovery and international privacy rules.